TFIIIB90-1 Polyclonal Antibody

货号：ES3588
价格：面议
点击：2145

产品介绍

抗体信息

应用	WB;IHC-p;IF/ICC;ELISA
反应种属	Human;Mouse
别称	BRF1; BRF; GTF3B; TAF3B2; TAF3C; Transcription factor IIIB 90 kDa subunit; TFIIIB90; hTFIIIB90; B-related factor 1; BRF-1; hBRF; TAF3B2; TATA box-binding protein-associated factor; RNA polymerase III, subunit 2

【仅供科学研究使用】

相关产品:

产品名称	点击数
Anti-Ixekizumab Non-Neutralizing Recombinant Antibody \|抗依奇珠单抗非中和重组抗体(靶标：依奇珠单抗非中和抗体)	438
Anti-Ixekizumab Non-Neutralizing Recombinant Antibody \|抗依奇珠单抗非中和重组抗体(靶标：依奇珠单抗非中和抗体)	444
Anti-Ixekizumab Non-Neutralizing Recombinant Antibody \|抗依奇珠单抗非中和重组抗体(靶标：依奇珠单抗非中和抗体)	649
Anti-Ixekizumab Neutralizing Recombinant Antibody \|抗依奇珠单抗中和重组抗体(靶标：依奇珠单抗中和抗体)	625
Anti-Ixekizumab Neutralizing Recombinant Antibody \|抗依奇珠单抗中和重组抗体(靶标：依奇珠单抗中和抗体)	551
Anti-Ixekizumab Neutralizing Recombinant Antibody \|抗依奇珠单抗中和重组抗体(靶标：依奇珠单抗中和抗体)	520
Anti-Daratumumab Non-Neutralizing Recombinant Antibody\|抗达雷妥尤单抗非中和重组抗体(靶标：达雷妥尤单抗非中和抗体)	595
Anti-Daratumumab Neutralizing Recombinant Antibody \|抗达雷妥尤单抗中和重组抗体(靶标：达雷妥尤单抗中和抗体)	612
Anti-Daratumumab Neutralizing Recombinant Antibody \|抗达雷妥尤单抗中和重组抗体(靶标：达雷妥尤单抗中和抗体)	573
Anti-Daratumumab Neutralizing Recombinant Antibody \|抗达雷妥尤单抗中和重组抗体(靶标：达雷妥尤单抗中和抗体)	684
Anti-Daratumumab Neutralizing Recombinant Antibody \|抗达雷妥尤单抗中和重组抗体(靶标：达雷妥尤单抗中和抗体)	641
Anti-Avelumab Non-Neutralizing Recombinant Antibody \|抗阿维鲁单抗非中和重组抗体(靶标：阿维鲁单抗非中和抗体)	359
Anti-Avelumab Non-Neutralizing Recombinant Antibody \|抗阿维鲁单抗非中和重组抗体(靶标：阿维鲁单抗非中和抗体)	463
Anti-Avelumab Non-Neutralizing Recombinant Antibody \|抗阿维鲁单抗非中和重组抗体(靶标：阿维鲁单抗非中和抗体)	630
Anti-Avelumab Non-Neutralizing Recombinant Antibody \|抗阿维鲁单抗非中和重组抗体(靶标：阿维鲁单抗非中和抗体)	463
Anti-Avelumab Neutralizing Recombinant Antibody \|抗阿维鲁单抗中和重组抗体(靶标：阿维鲁单抗中和抗体)	668
Anti-Avelumab Neutralizing Recombinant Antibody \|抗阿维鲁单抗中和重组抗体(靶标：阿维鲁单抗中和抗体)	455
Anti-Camrelizumab Neutralizing Recombinant Antibody \|抗卡瑞利珠单抗中和重组抗体(靶标：卡瑞利珠单抗中和抗体)	674
Anti-Camrelizumab Neutralizing Recombinant Antibody \|抗卡瑞利珠单抗中和重组抗体(靶标：卡瑞利珠单抗中和抗体)	660
Anti-Camrelizumab Neutralizing Recombinant Antibody \|抗卡瑞利珠单抗中和重组抗体(靶标：卡瑞利珠单抗中和抗体)	606